Investor Relations

Financial Releases

Date Title and Summary Additional Formats
Toggle Summary Intersect ENT Announces Publication of Pooled Analysis of Steroid Releasing Implants in Patients Following Frontal Sinus Surgery
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 15, 2018-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced publication of a pooled analysis in the International Forum of Allergy & Rhinology , the official
View HTML
Toggle Summary Intersect ENT to Present at the Piper Jaffray 30th Annual Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 7, 2018-- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will participate in the 30 th Annual Piper Jaffray Health Care Conference on November 28 at the Lotte New York Palace in New York City , and will present in a session at 10:30am ET
View HTML
Toggle Summary Intersect ENT Reports Third Quarter 2018 Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 5, 2018-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the third quarter ended September 30, 2018 .
View HTML
Toggle Summary Intersect ENT to Report Third Quarter 2018 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Oct. 17, 2018-- Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release third quarter financial results on November 5, 2018 .
View HTML
Toggle Summary Intersect ENT Reports Second Quarter 2018 Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Aug. 1, 2018-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2018 .
View HTML
Toggle Summary Intersect ENT to Report Second Quarter 2018 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Jul. 11, 2018-- Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its second quarter on August 1, 2018 .
View HTML
Toggle Summary Intersect ENT to Present at William Blair & Company 38th Annual Growth Stock Conference
MENLO PARK, Calif. --(BUSINESS WIRE)--May 29, 2018-- Intersect ENT, Inc. (Nasdaq: XENT ) today announced that management will present at the 38 th Annual William Blair Growth Stock Conference . The presentation is scheduled for June 12, 2018 at 11:30 a.m.
View HTML
Toggle Summary Intersect ENT Reports First Quarter 2018 Results
MENLO PARK, Calif. --(BUSINESS WIRE)--May 1, 2018-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the first quarter ended March 31, 2018 .
View HTML
Toggle Summary Intersect ENT to Present at Deutsche Bank and Bank of America Merrill Lynch Conferences
MENLO PARK, Calif. --(BUSINESS WIRE)--Apr. 17, 2018-- Intersect ENT, Inc. (Nasdaq: XENT ) today announced that management will present at Deutsche Bank’s 43 rd Annual Health Care Conference and at Bank of America Merrill Lynch 2018 Healthcare Conference.
View HTML
Toggle Summary Intersect ENT to Report First Quarter 2018 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Apr. 16, 2018-- Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its first quarter on May 1, 2018 .
View HTML